This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aubagnac, S.
Right arrow Articles by Bureau, J.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aubagnac, S.
Right arrow Articles by Bureau, J.-F.

 Previous Article  |  Next Article 

Journal of Virology, June 2002, p. 5807-5812, Vol. 76, No. 11
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.11.5807-5812.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Bone Marrow Chimeras Reveal Non-H-2 Hematopoietic Control of Susceptibility to Theiler's Virus Persistent Infection

Stéphanie Aubagnac, Michel Brahic, and Jean-François Bureau*

Unité des Virus Lents (CNRS URA 1930), Institut Pasteur, 75724 Paris Cedex 15, France

Received 27 November 2001/ Accepted 7 March 2002

The DA strain of Theiler's murine encephalomyelitis virus persists in the white matter of the spinal cords of susceptible mice. Previous results showed that the difference in susceptibility to viral persistence between the susceptible SJL/J strain and the resistant B10.S strain was due to multiple non-H-2 loci. The respective roles of hematopoietic and nonhematopoietic cells in this difference have been evaluated with bone marrow chimeras. The results show that non-H-2 loci with a major effect on susceptibility are expressed in hematopoietic cells. However, the study of the SJL.B10-D10Mit180-D10Mit74 congenic line suggests that other loci expressed in nonhematopoietic cells also play a role.

* Corresponding author. Mailing address: Unité des Virus Lents (CNRS URA 1930), Institut Pasteur, 28 rue du Dr. Roux, 75724 Paris Cedex 15, France. Phone: (33-1)40613325. Fax: (33-1)40613167. E-mail: jfb{at}pasteur.fr.

Journal of Virology, June 2002, p. 5807-5812, Vol. 76, No. 11
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.11.5807-5812.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Levillayer, F., Mas, M., Levi-Acobas, F., Brahic, M., Bureau, J. F. (2007). Interleukin 22 Is a Candidate Gene for Tmevp3, a Locus Controlling Theiler's Virus-Induced Neurological Diseases. Genetics 176: 1835-1844 [Abstract] [Full Text]  
  • Gao, Y., Yang, W., Pan, M., Scully, E., Girardi, M., Augenlicht, L. H., Craft, J., Yin, Z. (2003). {gamma}{delta} T Cells Provide an Early Source of Interferon {gamma} in Tumor Immunity. JEM 198: 433-442 [Abstract] [Full Text]  
  • Vigneau, S., Rohrlich, P.-S., Brahic, M., Bureau, J.-F. (2003). Tmevpg1, a Candidate Gene for the Control of Theiler's Virus Persistence, Could Be Implicated in the Regulation of Gamma Interferon. J. Virol. 77: 5632-5638 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»